We are live on ! Find out more
DCM

Driehaus Capital Management Portfolio holdings

AUM $13.6B
1-Year Est. Return 173.98%
This Fund
S&P 500
This Quarter Est. Return
+28.89%
1 Year Est. Return
+173.98%
3 Year Est. Return
+706.72%
5 Year Est. Return
+1,585.86%
10 Year Est. Return
+31,592.09%
AUM
$4.87B
AUM Growth
+$760M
Cap. Flow
-$2.18M
Cap. Flow %
-0.04%
Top 10 Hldgs %
26.33%
Holding
479
New
108
Increased
120
Reduced
143
Closed
93

Top Buys

Rank Stock Value
1
NKE icon
Nike
NKE
+$80.3M
2
AMD icon
Advanced Micro Devices
AMD
+$63M
3
U icon
Unity
U
+$41.2M
4
RLAY icon
Relay Therapeutics
RLAY
+$40.9M
5
RIO icon
Rio Tinto
RIO
+$37.9M

Sector Composition

Rank Sector Weight
1 Technology 23.72%
2 Consumer Discretionary 22.8%
3 Healthcare 20.94%
4 Financials 8.5%
5 Industrials 7.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TSM icon
1
TSMC
TSM
$2.09T
$344M 7.06%
4,245,190
+37,797
+0.9% +$2.87M
BABA icon
2
Alibaba
BABA
$269B
$331M 6.79%
1,125,541
-292,490
-21% -$77.1M
SE icon
3
Sea Limited
SE
$61.2B
$96M 1.97%
623,073
+175,487
+39% +$23.7M
NKE icon
4
Nike
NKE
$61.9B
$94M 1.93%
+748,402
New +$80.3M
HDB icon
5
HDFC Bank
HDB
$119B
$78M 1.6%
3,123,080
+611,340
+24% +$14.8M
MYOK
6
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$70.6M 1.45%
517,691
-34,409
-6% -$3.66M
AMD icon
7
Advanced Micro Devices
AMD
$851B
$70.1M 1.44%
855,312
+848,999
+13,448% +$63M
JD icon
8
JD.com
JD
$40.8B
$69.2M 1.42%
890,993
-99,656
-10% -$6.92M
CYTK icon
9
Cytokinetics
CYTK
$11B
$65.6M 1.35%
3,031,698
-77,674
-2% -$1.82M
SITM icon
10
SiTime
SITM
$16.6B
$64.2M 1.32%
763,572
+15,189
+2% +$946K
BAND
11
Bandwidth Inc
BAND
$1.91B
$58.3M 1.2%
333,752
+137,880
+70% +$20.4M
NTRA icon
12
Natera
NTRA
$37.5B
$57.6M 1.18%
797,199
+16,828
+2% +$957K
NVDA icon
13
NVIDIA
NVDA
$5.01T
$53.4M 1.1%
3,950,120
-951,200
-19% -$11.1M
IBN icon
14
ICICI Bank
IBN
$106B
$49.3M 1.01%
5,017,056
-772,349
-13% -$7.69M
SWTX
15
DELISTED
SpringWorks Therapeutics
SWTX
$46.5M 0.95%
974,915
-31,687
-3% -$1.35M
RLAY icon
16
Relay Therapeutics
RLAY
$4.02B
$45.7M 0.94%
+1,073,009
New +$40.9M
ONC
17
BeOne Medicines Ltd
ONC
$33.8B
$44.3M 0.91%
+154,666
New +$36.4M
PLMR icon
18
Palomar
PLMR
$3.65B
$42.6M 0.88%
408,911
-25,664
-6% -$2.52M
U icon
19
Unity
U
$12.5B
$42.6M 0.87%
+488,240
New +$41.2M
DAVA icon
20
Endava
DAVA
$141M
$42.1M 0.87%
667,365
-181,041
-21% -$9.81M
TNDM icon
21
Tandem Diabetes Care
TNDM
$1.17B
$40.9M 0.84%
360,670
-935
-0.3% -$98.2K
INSP icon
22
Inspire Medical Systems
INSP
$1.42B
$40.8M 0.84%
316,368
-17,643
-5% -$1.94M
SPOT icon
23
Spotify
SPOT
$99.2B
$40.6M 0.83%
167,223
+36,461
+28% +$9.42M
EPI icon
24
WisdomTree India Earnings Fund ETF
EPI
$2.02B
$40.1M 0.82%
1,700,801
+50,813
+3% +$1.15M
NBIS
25
Nebius Group N.V.
NBIS
$47.7B
$38.8M 0.8%
593,895
-325,607
-35% -$19.4M

Similar funds

Driehaus Capital Management's Q3 2020 Portfolio in Review

As of Q3 2020, Driehaus Capital Management held 479 positions worth $4.87B, up 18% from $4.11B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Driehaus Capital Management's Q3 2020 filing shows 108 new, 120 increased, 143 reduced and 93 closed positions. Its largest new stake was Nike: 748,402 shares worth $94M. The largest sale was Alibaba, an estimated $77.1M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Driehaus Capital Management's largest Q3 2020 buy was Nike: 748,402 shares worth $94M.
  • Driehaus Capital Management added most to Advanced Micro Devices in Q3 2020, an estimated $63M increase.
  • Driehaus Capital Management's biggest Q3 2020 reduction was Alibaba, cutting an estimated $77.1M.
  • Driehaus Capital Management fully exited Analog Devices in Q3 2020, selling an estimated $43.3M.
  • Driehaus Capital Management's ten largest holdings make up 26% of its $4.87B portfolio in Q3 2020.
  • Driehaus Capital Management opened 108 new positions and closed 93 in Q3 2020.
  • Driehaus Capital Management's portfolio value rose 18% quarter-over-quarter to $4.87B.

Based on Driehaus Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.